Mid-year benefits review: What employers miss before renewal

Mid-year is one of the most misleading periods in employee benefits planning. Claims appear stable, renewal is still months away and many employers assume their health plan is tracking as expected. Yet some of the most significant cost drivers emerge during the second half of the year, often after key strategic decisions should already have been made.

For employers sponsoring self-funded health plans, mid-year is the ideal time to identify emerging risks and evaluate whether current strategies remain aligned with plan performance. These are my top tips and insights for employers who want to create an effective, proactive benefits strategy, instead of hoping for the best as renewal season approaches.

Flat spending does not mean all is well

When aggregate spend looks flat or within range through the first half of the year, the instinct is to treat that as a sign of security. But mid-year data only tells part of the story, and the part it tells is often the least predictive one.

Healthcare claims tend to be unevenly distributed throughout the year. A plan that looks stable in June can look very different by October after a few large claimants appear or specialty medications are initiated. Employers should be aware of the danger of treating mid-year spending as confirmation of a larger trend.

There's also a data lag problem here. Claims data is inherently retrospective. What employers are reviewing mid-year may not fully reflect services already incurred but not yet reported, or utilization shifts that are still developing. I often see cases where the plan appears stable during mid-year reviews, only to experience significant cost pressure as previously unseen claims emerge later in the year.

Finally, many employers are still calibrating 2026 against historical patterns that no longer apply. Healthcare costs and utilization are shifting faster than traditional forecasting models were designed to accommodate, particularly in specialty pharmacy, behavioral health and high-acuity care. Thus, last year's trend is not a reliable guide to next year's exposure.

Where volatility is building

Three categories deserve more attention than they're currently getting in mid-year reviews:

1. Specialty pharmacy remains one of the most underestimated drivers of plan volatility. A single specialty medication claimant can add hundreds of thousands of dollars in annual plan expense, particularly when treatment begins mid-year and was not reflected in prior utilization patterns.

In many self-funded plans, specialty drugs now account for a disproportionate share of total pharmacy spending despite serving a relatively small percentage of members. Many employers are still managing pharmacy exposure with strategies that predate the current pace of market development. This leaves meaningful risk unaddressed.

2. Behavioral health utilization continues to increase. That's not inherently a problem. I think we can all agree that employees accessing the care they need is a positive development. But organizations must understand how those utilization changes affect overall plan performance, workforce productivity and long-term healthcare risk. The financial impact of increasing access must be examined lest it give risk a place to hide.

3. A steady increase in outpatient procedures, emergency room visits, imaging or specialty referrals can signal larger cost pressures that are still developing. This category is harder to spot because it concerns frequency rather than claim size, but it’s important to monitor. If employers focus only on the size of individual claims, this kind of slow-building utilization trend can go unnoticed until renewal, when employers have fewer opportunities to make meaningful strategic adjustments.

Questions employers should ask right now

When employers wait until renewal season to evaluate risk, they typically discover they have fewer options to tweak plan design than they anticipated. At that point, they would love to evaluate alternative funding arrangements, strengthen clinical management programs or take steps to fully prepare employees for open enrollment, but there’s no time.

What tends to happen instead is a reactive focus on short-term premium impact. This is understandable given the timeline, but it’s also not the same thing as a benefits strategy. I find the difference between employers who are ready at renewal and those who are surprised is often when they started asking the right questions:

• What percentage of plan spend is coming from specialty pharmacies?
• Are any high-cost claimants approaching stop-loss thresholds?
• Which utilization categories are growing fastest?
• Are employees engaging with care management programs?
• Is our stop-loss strategy still appropriate for our current risk levels?

A deeper claims and utilization review conducted now can surface trend drivers that might stay hidden otherwise. That requires looking beyond total claims cost to fundamental shifts within the plan. Employers should also evaluate emerging large claimant activity and stop-loss performance trends. Understanding where high-cost cases are developing can help organizations anticipate future exposure, assess reimbursement expectations and identify opportunities for clinical intervention before renewal discussions begin.

Mid-year is also the right time to reassess pharmacy management strategies and assess how well the current vendor ecosystem is performing. Network performance, case management engagement and member advocacy resources are worth examining before they become renewal-season complaints.

For brokers and consultants, mid-year reviews provide an opportunity to demonstrate strategic value by helping clients interpret emerging trends, evaluate risk drivers and identify opportunities for intervention before renewal discussions begin.

Clients increasingly need partners who can help interpret data and identify emerging risks rather than manage the mechanics of renewal. The employers who engage their brokers and third-party administrators as strategic advisors mid-year consistently end up with more options and better outcomes.

The most successful self-funded employers are no longer treating benefits strategy as an annual renewal exercise. They are continuously monitoring plan performance, identifying emerging risks, and making informed adjustments throughout the year. In today's healthcare environment, proactive planning is no longer optional; it’s a competitive advantage.

© Entire contents copyright 2026 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.

Charlene Zielinski is chief client services officer at Nova Healthcare Administrators. Contact her at [email protected].